We are dedicated
to develop drugs for neurological disorders
Our vocation is to develop first-in-class innovative drugs to treat patients with traumatic or severe neurological disorders with high unmet medical needs.
During embryogenesis, a small organ named Subcommisural Organ (SCO) located in the dorsal roof of the brain differentiates and secrets a protein, the SCO-spondin, a naturally secreted protein with potent activity during neurogenesis.
Our products are small peptides derived from thrombospondin repeat
NX210 and analogs are first-in class multi-functional patented peptides.
NX210 has multifunctional activities on neurons:
Neurological disorders are diseases of the central and peripheral nervous system including epilepsy, These disorders are of major clinical problems with unmet medical needs and no satisfactory treatment.